# Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily

> **NCT01121809** · PHASE4 · COMPLETED · sponsor: **Hospitales Universitarios Virgen del Rocío** · enrollment: 16 (actual)

## Conditions studied

- HIV-1 Infection
- HIV Infections

## Interventions

- **DRUG:** Raltegravir
- **DRUG:** Etravirine

## Key facts

- **NCT ID:** NCT01121809
- **Lead sponsor:** Hospitales Universitarios Virgen del Rocío
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-10
- **Final completion:** 2011-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2011-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01121809

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01121809, "Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01121809. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*